Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Astrazeneca (AZN) Share News

12345678910

AstraZeneca to pay up to USD1 billion for cell therapy firm, EsoBiotec

17th Mar 2025 08:57

(Alliance News) - AstraZeneca PLC on Monday announced an acquisition, a license agreement, regulatory approval in Europe for cancer drug Imfinzi, and a further positive product update in a busy start to the week. Read More

LONDON BRIEFING: Phoenix Group "ahead of plan"; AstraZeneca makes buy

17th Mar 2025 07:49

(Alliance News) - Stocks in London are called to open flat on Monday, as investors digest plans by Chinese officials to boost consumption there, before focus later this week turns to central bank decisions. Read More

LONDON MARKET MIDDAY: Stocks down but eurozone GDP beats forecasts

7th Mar 2025 12:03

(Alliance News) - Stock prices in London were lower midday on Friday, as investors remain nervous despite the latest pause on certain US tariffs. Read More

AstraZeneca finds Imfinzi improves survival rates for gastric cancers

7th Mar 2025 09:59

(Alliance News) - AstraZeneca PLC on Friday said its Imfinzi treatment has demonstrated statistically significant results in a trial testing survival rates in stomach cancers. Read More

AstraZeneca lung cancer therapy Imfinzi recommended for EU approval

3rd Mar 2025 11:13

(Alliance News) - AstraZeneca PLC on Monday said its lung cancer drug Imfinzi has been recommended for approval in the EU. Read More

LONDON BRIEFING: FTSE 100 up ahead of UK and US PMI readings

3rd Mar 2025 07:49

(Alliance News) - Stocks were called higher on Monday morning as investors digest news of greater-than-expected acceleration in China's manufacturing sector, while Japan's saw a softer deterioration than forecast. Read More

AstraZeneca, Amgen drug shows positive results in nasal polyps trials

2nd Mar 2025 08:16

(Alliance News) - An asthma drug has shown positive results when used to treat nasal polyps, researchers have said. Read More

AstraZeneca breast cancer therapy wins recommendation for EU approval

28th Feb 2025 15:26

(Alliance News) - AstraZeneca PLC on Friday said its breast cancer therapy, Enhertu, which is being developed jointly with Tokyo-based pharmaceutical company Daiichi Sankyo Co Ltd, has been recommended for approval in the EU. Read More

AstraZeneca's camizestrant has benefit in advanced breast cancer trial

26th Feb 2025 09:27

(Alliance News) - AstraZeneca PLC on Wednesday said its drug camizestrant significantly delayed disease progression in a phase III trial for advanced hormone receptor-positive breast cancer, supporting its potential as a new treatment option. Read More

LONDON MARKET CLOSE: Lloyds and Centrica star on down day for FTSE 100

20th Feb 2025 16:57

(Alliance News) - The FTSE 100 ended lower on Thursday, not helped by a weak start on Wall Street, hurt by a handful of its heavyweight names going ex-dividend. Read More

LONDON MARKET MIDDAY: Ex-dividend stocks stifle FTSE 100

20th Feb 2025 12:09

(Alliance News) - European blue-chips traded mixed on Thursday afternoon, with measures in Paris and Frankfurt rising, but that same positivity eluding the FTSE 100 in London. Read More

LONDON MARKET OPEN: FTSE 100 underperforms but Centrica jumps

20th Feb 2025 09:04

(Alliance News) - European stocks opened mixed on Thursday, with the FTSE 100 underperforming, as Russia-Ukraine uncertainty, tariff worries and the possibility of higher for longer interest rates cloud over stocks. Read More

LONDON MARKET MIDDAY: Strong pound pegs FTSE 100 but mid-caps prosper

14th Feb 2025 11:58

(Alliance News) - The FTSE 100 traded lower around midday, as gains in sterling kept a lid on some dollar earners offsetting strong gains in miners. Read More

UK dividends calendar - next 7 days

13th Feb 2025 14:02

Read More

LONDON BROKER RATINGS: UBS raises AstraZeneca to 'buy'

13th Feb 2025 09:35

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and on Wednesday: Read More

LONDON BRIEFING: Barclays and Unilever announce buybacks

13th Feb 2025 07:54

(Alliance News) - London's FTSE 100 is called to open slightly lower on Thursday, while the pound climbed after better-than-expected UK data. Read More

LONDON BROKER RATINGS: Morgan Stanley likes Astra; HSBC cuts Spectris

12th Feb 2025 09:58

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday: Read More

LONDON BRIEFING: Barratt Redrow eyes profit at top end of market view

12th Feb 2025 07:49

(Alliance News) - London's FTSE 100 is called to open flat on Wednesday, failing to replicate some more confident trade seen in Asia, with a US inflation reading ahead. Read More

LONDON BROKER RATINGS: Peel Hunt raises Fevertree to 'hold'

11th Feb 2025 09:52

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and on Monday: Read More

LONDON BROKER RATINGS: Deutsche Bank raises Victrex, cuts Fevertree

10th Feb 2025 09:59

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and on Friday: Read More

12345678910
FTSE 100 Latest
Value8,275.66
Change0.00